nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—GRIN2B—Parkinson's disease	0.422	0.581	CbGaD
Pethidine—SLC6A3—Parkinson's disease	0.199	0.275	CbGaD
Pethidine—CYP2D6—Parkinson's disease	0.105	0.144	CbGaD
Pethidine—GRIN1—telencephalic ventricle—Parkinson's disease	0.00483	0.0454	CbGeAlD
Pethidine—GRIN2B—telencephalic ventricle—Parkinson's disease	0.0046	0.0433	CbGeAlD
Pethidine—SLC6A2—locus ceruleus—Parkinson's disease	0.00378	0.0355	CbGeAlD
Pethidine—GRIN2C—nerve—Parkinson's disease	0.00367	0.0345	CbGeAlD
Pethidine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00299	0.0281	CbGeAlD
Pethidine—GRIN2B—nerve—Parkinson's disease	0.0029	0.0273	CbGeAlD
Pethidine—GRIN2C—hindbrain—Parkinson's disease	0.00275	0.0258	CbGeAlD
Pethidine—GRIN2D—hindbrain—Parkinson's disease	0.00256	0.024	CbGeAlD
Pethidine—GRIN2A—nerve—Parkinson's disease	0.00254	0.0238	CbGeAlD
Pethidine—OPRM1—telencephalic ventricle—Parkinson's disease	0.00245	0.023	CbGeAlD
Pethidine—GRIN1—hindbrain—Parkinson's disease	0.00228	0.0214	CbGeAlD
Pethidine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00222	0.0209	CbGeAlD
Pethidine—GRIN2B—hindbrain—Parkinson's disease	0.00217	0.0204	CbGeAlD
Pethidine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00201	0.0189	CbGeAlD
Pethidine—GRIN2A—hindbrain—Parkinson's disease	0.0019	0.0179	CbGeAlD
Pethidine—GRIN2C—brainstem—Parkinson's disease	0.00158	0.0148	CbGeAlD
Pethidine—OPRM1—nerve—Parkinson's disease	0.00154	0.0145	CbGeAlD
Pethidine—GRIN2C—forebrain—Parkinson's disease	0.00152	0.0143	CbGeAlD
Pethidine—GRIN2D—brainstem—Parkinson's disease	0.00147	0.0138	CbGeAlD
Pethidine—GRIN2D—forebrain—Parkinson's disease	0.00141	0.0133	CbGeAlD
Pethidine—SLC6A3—nerve—Parkinson's disease	0.0014	0.0132	CbGeAlD
Pethidine—GRIN1—brainstem—Parkinson's disease	0.00131	0.0123	CbGeAlD
Pethidine—GRIN1—forebrain—Parkinson's disease	0.00126	0.0118	CbGeAlD
Pethidine—GRIN2B—brainstem—Parkinson's disease	0.00125	0.0117	CbGeAlD
Pethidine—GRIN2B—forebrain—Parkinson's disease	0.0012	0.0113	CbGeAlD
Pethidine—SLC6A2—nerve—Parkinson's disease	0.00113	0.0106	CbGeAlD
Pethidine—GRIN2C—medulla oblongata—Parkinson's disease	0.0011	0.0103	CbGeAlD
Pethidine—GRIN2A—brainstem—Parkinson's disease	0.00109	0.0102	CbGeAlD
Pethidine—GRIN2A—forebrain—Parkinson's disease	0.00105	0.00988	CbGeAlD
Pethidine—SLC6A3—hindbrain—Parkinson's disease	0.00105	0.00985	CbGeAlD
Pethidine—GRIN2D—medulla oblongata—Parkinson's disease	0.00102	0.0096	CbGeAlD
Pethidine—SLC6A4—hindbrain—Parkinson's disease	0.00096	0.00903	CbGeAlD
Pethidine—GRIN2D—spinal cord—Parkinson's disease	0.000911	0.00856	CbGeAlD
Pethidine—OPRK1—forebrain—Parkinson's disease	0.000898	0.00844	CbGeAlD
Pethidine—Methylphenobarbital—GRIK2—Parkinson's disease	0.000876	0.289	CrCbGaD
Pethidine—GRIN2C—head—Parkinson's disease	0.000871	0.00819	CbGeAlD
Pethidine—GRIN1—midbrain—Parkinson's disease	0.000832	0.00782	CbGeAlD
Pethidine—GRIN2C—nervous system—Parkinson's disease	0.000826	0.00776	CbGeAlD
Pethidine—GRIN1—spinal cord—Parkinson's disease	0.000812	0.00763	CbGeAlD
Pethidine—GRIN2D—head—Parkinson's disease	0.00081	0.00761	CbGeAlD
Pethidine—GRIN2C—central nervous system—Parkinson's disease	0.000795	0.00747	CbGeAlD
Pethidine—GRIN2C—cerebellum—Parkinson's disease	0.000777	0.0073	CbGeAlD
Pethidine—GRIN2B—spinal cord—Parkinson's disease	0.000775	0.00728	CbGeAlD
Pethidine—GRIN2D—nervous system—Parkinson's disease	0.000768	0.00722	CbGeAlD
Pethidine—GRIN2A—medulla oblongata—Parkinson's disease	0.000759	0.00714	CbGeAlD
Pethidine—Methylphenobarbital—CHRNA4—Parkinson's disease	0.000749	0.247	CrCbGaD
Pethidine—GRIN2D—central nervous system—Parkinson's disease	0.000739	0.00695	CbGeAlD
Pethidine—GRIN2D—cerebellum—Parkinson's disease	0.000722	0.00679	CbGeAlD
Pethidine—GRIN1—head—Parkinson's disease	0.000722	0.00678	CbGeAlD
Pethidine—GRIN2A—midbrain—Parkinson's disease	0.000694	0.00652	CbGeAlD
Pethidine—GRIN2B—head—Parkinson's disease	0.000688	0.00647	CbGeAlD
Pethidine—GRIN1—nervous system—Parkinson's disease	0.000684	0.00643	CbGeAlD
Pethidine—GRIN2A—spinal cord—Parkinson's disease	0.000677	0.00636	CbGeAlD
Pethidine—OPRM1—brainstem—Parkinson's disease	0.000662	0.00622	CbGeAlD
Pethidine—GRIN1—central nervous system—Parkinson's disease	0.000659	0.00619	CbGeAlD
Pethidine—GRIN2B—nervous system—Parkinson's disease	0.000653	0.00614	CbGeAlD
Pethidine—GRIN1—cerebellum—Parkinson's disease	0.000644	0.00605	CbGeAlD
Pethidine—OPRM1—forebrain—Parkinson's disease	0.000639	0.00601	CbGeAlD
Pethidine—GRIN2C—brain—Parkinson's disease	0.000631	0.00593	CbGeAlD
Pethidine—GRIN2B—central nervous system—Parkinson's disease	0.000628	0.00591	CbGeAlD
Pethidine—GRIN2B—cerebellum—Parkinson's disease	0.000614	0.00577	CbGeAlD
Pethidine—GRIN2A—head—Parkinson's disease	0.000602	0.00566	CbGeAlD
Pethidine—SLC6A3—brainstem—Parkinson's disease	0.000601	0.00565	CbGeAlD
Pethidine—GRIN2D—brain—Parkinson's disease	0.000587	0.00552	CbGeAlD
Pethidine—SLC6A3—forebrain—Parkinson's disease	0.00058	0.00545	CbGeAlD
Pethidine—GRIN2A—nervous system—Parkinson's disease	0.00057	0.00536	CbGeAlD
Pethidine—Levomilnacipran—CYP2D6—Parkinson's disease	0.000564	0.186	CrCbGaD
Pethidine—SLC6A4—brainstem—Parkinson's disease	0.00055	0.00517	CbGeAlD
Pethidine—GRIN2A—central nervous system—Parkinson's disease	0.000549	0.00516	CbGeAlD
Pethidine—GRIN2A—cerebellum—Parkinson's disease	0.000537	0.00505	CbGeAlD
Pethidine—SLC6A4—forebrain—Parkinson's disease	0.000531	0.00499	CbGeAlD
Pethidine—GRIN1—brain—Parkinson's disease	0.000523	0.00492	CbGeAlD
Pethidine—OPRK1—head—Parkinson's disease	0.000514	0.00483	CbGeAlD
Pethidine—GRIN2B—brain—Parkinson's disease	0.000499	0.00469	CbGeAlD
Pethidine—OPRK1—nervous system—Parkinson's disease	0.000487	0.00458	CbGeAlD
Pethidine—SLC6A2—brainstem—Parkinson's disease	0.000485	0.00456	CbGeAlD
Pethidine—OPRK1—central nervous system—Parkinson's disease	0.000469	0.00441	CbGeAlD
Pethidine—SLC6A2—forebrain—Parkinson's disease	0.000468	0.0044	CbGeAlD
Pethidine—CYP2D6—hindbrain—Parkinson's disease	0.000463	0.00435	CbGeAlD
Pethidine—OPRK1—cerebellum—Parkinson's disease	0.000459	0.00431	CbGeAlD
Pethidine—Glutethimide—CYP2D6—Parkinson's disease	0.000439	0.145	CrCbGaD
Pethidine—GRIN2A—brain—Parkinson's disease	0.000436	0.0041	CbGeAlD
Pethidine—OPRM1—midbrain—Parkinson's disease	0.000422	0.00397	CbGeAlD
Pethidine—OPRM1—spinal cord—Parkinson's disease	0.000412	0.00387	CbGeAlD
Pethidine—Levomilnacipran—ABCB1—Parkinson's disease	0.000403	0.133	CrCbGaD
Pethidine—ORM1—spinal cord—Parkinson's disease	0.000402	0.00378	CbGeAlD
Pethidine—SLC6A3—midbrain—Parkinson's disease	0.000383	0.0036	CbGeAlD
Pethidine—SLC6A3—spinal cord—Parkinson's disease	0.000374	0.00351	CbGeAlD
Pethidine—OPRK1—brain—Parkinson's disease	0.000373	0.0035	CbGeAlD
Pethidine—OPRM1—head—Parkinson's disease	0.000366	0.00344	CbGeAlD
Pethidine—SLC6A4—midbrain—Parkinson's disease	0.000351	0.0033	CbGeAlD
Pethidine—OPRM1—nervous system—Parkinson's disease	0.000347	0.00326	CbGeAlD
Pethidine—SLC6A4—spinal cord—Parkinson's disease	0.000342	0.00322	CbGeAlD
Pethidine—ORM1—nervous system—Parkinson's disease	0.000338	0.00318	CbGeAlD
Pethidine—SLC6A2—medulla oblongata—Parkinson's disease	0.000338	0.00318	CbGeAlD
Pethidine—OPRM1—central nervous system—Parkinson's disease	0.000334	0.00314	CbGeAlD
Pethidine—SLC6A3—head—Parkinson's disease	0.000332	0.00312	CbGeAlD
Pethidine—ORM1—central nervous system—Parkinson's disease	0.000326	0.00306	CbGeAlD
Pethidine—SLC6A3—nervous system—Parkinson's disease	0.000315	0.00296	CbGeAlD
Pethidine—SLC6A4—head—Parkinson's disease	0.000304	0.00286	CbGeAlD
Pethidine—SLC6A3—central nervous system—Parkinson's disease	0.000303	0.00285	CbGeAlD
Pethidine—SLC6A3—cerebellum—Parkinson's disease	0.000296	0.00278	CbGeAlD
Pethidine—CYP2B6—cardiovascular system—Parkinson's disease	0.000291	0.00274	CbGeAlD
Pethidine—SLC6A4—nervous system—Parkinson's disease	0.000288	0.00271	CbGeAlD
Pethidine—SLC6A4—central nervous system—Parkinson's disease	0.000278	0.00261	CbGeAlD
Pethidine—SLC6A2—head—Parkinson's disease	0.000268	0.00252	CbGeAlD
Pethidine—CYP2D6—brainstem—Parkinson's disease	0.000265	0.00249	CbGeAlD
Pethidine—OPRM1—brain—Parkinson's disease	0.000265	0.00249	CbGeAlD
Pethidine—CYP2D6—forebrain—Parkinson's disease	0.000256	0.00241	CbGeAlD
Pethidine—SLC6A2—nervous system—Parkinson's disease	0.000254	0.00239	CbGeAlD
Pethidine—SLC6A2—central nervous system—Parkinson's disease	0.000244	0.0023	CbGeAlD
Pethidine—SLC6A3—brain—Parkinson's disease	0.000241	0.00226	CbGeAlD
Pethidine—ALB—brain—Parkinson's disease	0.000227	0.00213	CbGeAlD
Pethidine—SLC6A4—brain—Parkinson's disease	0.00022	0.00207	CbGeAlD
Pethidine—CYP2B6—head—Parkinson's disease	0.000197	0.00186	CbGeAlD
Pethidine—SLC6A2—brain—Parkinson's disease	0.000194	0.00182	CbGeAlD
Pethidine—CYP2B6—nervous system—Parkinson's disease	0.000187	0.00176	CbGeAlD
Pethidine—CYP2B6—central nervous system—Parkinson's disease	0.00018	0.00169	CbGeAlD
Pethidine—CYP2D6—head—Parkinson's disease	0.000147	0.00138	CbGeAlD
Pethidine—CYP2B6—brain—Parkinson's disease	0.000143	0.00134	CbGeAlD
Pethidine—CYP3A4—nervous system—Parkinson's disease	0.000141	0.00133	CbGeAlD
Pethidine—CYP2D6—nervous system—Parkinson's disease	0.000139	0.00131	CbGeAlD
Pethidine—CYP3A4—central nervous system—Parkinson's disease	0.000136	0.00128	CbGeAlD
Pethidine—CYP2D6—central nervous system—Parkinson's disease	0.000134	0.00126	CbGeAlD
Pethidine—CYP2D6—cerebellum—Parkinson's disease	0.000131	0.00123	CbGeAlD
Pethidine—CYP2D6—brain—Parkinson's disease	0.000106	0.000999	CbGeAlD
Pethidine—ALB—Metabolism—ND3—Parkinson's disease	1.95e-05	0.000118	CbGpPWpGaD
Pethidine—ALB—Metabolism—MCCC1—Parkinson's disease	1.95e-05	0.000118	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	1.93e-05	0.000117	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.92e-05	0.000116	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	1.91e-05	0.000116	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.9e-05	0.000115	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDYN—Parkinson's disease	1.89e-05	0.000115	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.86e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD2—Parkinson's disease	1.86e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HTR7—Parkinson's disease	1.86e-05	0.000113	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	1.86e-05	0.000113	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	1.85e-05	0.000112	CbGpPWpGaD
Pethidine—ALB—Metabolism—OMD—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Pethidine—ALB—Metabolism—TALDO1—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.82e-05	0.00011	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL6—Parkinson's disease	1.82e-05	0.00011	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	1.81e-05	0.00011	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	1.8e-05	0.000109	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	1.79e-05	0.000108	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.79e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GFAP—Parkinson's disease	1.78e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GRM5—Parkinson's disease	1.76e-05	0.000107	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—FBP1—Parkinson's disease	1.76e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GBA—Parkinson's disease	1.76e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DBH—Parkinson's disease	1.76e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ND3—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PENK—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAG—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Pethidine—ALB—Hemostasis—FGB—Parkinson's disease	1.74e-05	0.000106	CbGpPWpGaD
Pethidine—ALB—Metabolism—NDUFB11—Parkinson's disease	1.74e-05	0.000105	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	1.74e-05	0.000105	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Pethidine—ALB—Metabolism—GCH1—Parkinson's disease	1.66e-05	0.0001	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—OMD—Parkinson's disease	1.65e-05	9.97e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	1.65e-05	9.97e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—EDN1—Parkinson's disease	1.64e-05	9.93e-05	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	1.62e-05	9.83e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.62e-05	9.83e-05	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	1.62e-05	9.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	1.61e-05	9.76e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ND3—Parkinson's disease	1.61e-05	9.75e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	1.61e-05	9.75e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	1.6e-05	9.7e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	1.6e-05	9.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	1.59e-05	9.65e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	1.57e-05	9.52e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	1.57e-05	9.52e-05	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—IL6—Parkinson's disease	1.57e-05	9.51e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	1.56e-05	9.45e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGF20—Parkinson's disease	1.54e-05	9.35e-05	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—IL6—Parkinson's disease	1.53e-05	9.27e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.52e-05	9.17e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—OMD—Parkinson's disease	1.52e-05	9.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	1.51e-05	9.11e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ADORA2A—Parkinson's disease	1.5e-05	9.06e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.5e-05	9.06e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GCH1—Parkinson's disease	1.49e-05	9.02e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EDN1—Parkinson's disease	1.49e-05	9.02e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	1.49e-05	9.01e-05	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.49e-05	8.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GBA—Parkinson's disease	1.48e-05	8.95e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—FBP1—Parkinson's disease	1.48e-05	8.95e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—DBH—Parkinson's disease	1.48e-05	8.95e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.47e-05	8.87e-05	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	1.45e-05	8.75e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.44e-05	8.69e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.44e-05	8.69e-05	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TNF—Parkinson's disease	1.39e-05	8.41e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	1.39e-05	8.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—INSR—Parkinson's disease	1.38e-05	8.36e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.37e-05	8.29e-05	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—Parkinson's disease	1.35e-05	8.2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.34e-05	8.13e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DBH—Parkinson's disease	1.33e-05	8.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GBA—Parkinson's disease	1.33e-05	8.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—FBP1—Parkinson's disease	1.33e-05	8.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGB—Parkinson's disease	1.31e-05	7.91e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	1.31e-05	7.9e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	1.3e-05	7.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	1.3e-05	7.86e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SOD1—Parkinson's disease	1.29e-05	7.83e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.29e-05	7.82e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DDC—Parkinson's disease	1.29e-05	7.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	1.28e-05	7.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.27e-05	7.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	1.26e-05	7.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	1.25e-05	7.59e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.24e-05	7.51e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—ABL1—Parkinson's disease	1.23e-05	7.47e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF2—Parkinson's disease	1.23e-05	7.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.22e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.22e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.22e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	1.22e-05	7.37e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	1.22e-05	7.36e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.21e-05	7.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INSR—Parkinson's disease	1.17e-05	7.07e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HGF—Parkinson's disease	1.16e-05	7.03e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	1.13e-05	6.87e-05	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—IL6—Parkinson's disease	1.12e-05	6.79e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGB—Parkinson's disease	1.1e-05	6.68e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.1e-05	6.67e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	1.1e-05	6.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	1.1e-05	6.65e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.1e-05	6.65e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	1.1e-05	6.64e-05	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—IL6—Parkinson's disease	1.09e-05	6.62e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—DDC—Parkinson's disease	1.09e-05	6.57e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MAOB—Parkinson's disease	1.09e-05	6.57e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	1.08e-05	6.55e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.08e-05	6.53e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	1.06e-05	6.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.05e-05	6.38e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.05e-05	6.38e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.04e-05	6.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	1.03e-05	6.22e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTA4—Parkinson's disease	1.03e-05	6.2e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.01e-05	6.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—OMD—Parkinson's disease	9.91e-06	5.99e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	9.91e-06	5.99e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DDC—Parkinson's disease	9.75e-06	5.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.59e-06	5.8e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	9.39e-06	5.68e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	9.29e-06	5.62e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	9.29e-06	5.62e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PLA2G6—Parkinson's disease	9.23e-06	5.59e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	9.21e-06	5.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	9.2e-06	5.57e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MAOB—Parkinson's disease	9.14e-06	5.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.09e-06	5.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DDC—Parkinson's disease	8.96e-06	5.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCH1—Parkinson's disease	8.96e-06	5.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	8.91e-06	5.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	8.8e-06	5.33e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.7e-06	5.26e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	8.46e-06	5.12e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	8.29e-06	5.01e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MAOB—Parkinson's disease	8.2e-06	4.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NGF—Parkinson's disease	8.09e-06	4.89e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	8.07e-06	4.88e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FBP1—Parkinson's disease	7.98e-06	4.83e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GBA—Parkinson's disease	7.98e-06	4.83e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DBH—Parkinson's disease	7.98e-06	4.83e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CTGF—Parkinson's disease	7.92e-06	4.79e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.81e-06	4.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	7.78e-06	4.71e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	7.7e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	7.62e-06	4.61e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.54e-06	4.57e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	7.53e-06	4.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	7.44e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	7.38e-06	4.47e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NQO1—Parkinson's disease	7.3e-06	4.42e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TH—Parkinson's disease	7.19e-06	4.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOE—Parkinson's disease	7.16e-06	4.33e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYCS—Parkinson's disease	6.9e-06	4.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NGF—Parkinson's disease	6.83e-06	4.14e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2D6—Parkinson's disease	6.79e-06	4.11e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CTGF—Parkinson's disease	6.67e-06	4.03e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	6.51e-06	3.94e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2E1—Parkinson's disease	6.21e-06	3.76e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NQO1—Parkinson's disease	6.14e-06	3.72e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—COMT—Parkinson's disease	6.11e-06	3.7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—INS—Parkinson's disease	6.11e-06	3.7e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	6.1e-06	3.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	6.09e-06	3.68e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MAOA—Parkinson's disease	6.07e-06	3.67e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—TH—Parkinson's disease	6.05e-06	3.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—Parkinson's disease	6.05e-06	3.66e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	6e-06	3.63e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CTGF—Parkinson's disease	5.98e-06	3.62e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DDC—Parkinson's disease	5.86e-06	3.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYCS—Parkinson's disease	5.81e-06	3.52e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	5.76e-06	3.49e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	5.59e-06	3.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	5.58e-06	3.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.53e-06	3.35e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NQO1—Parkinson's disease	5.51e-06	3.34e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.5e-06	3.33e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TH—Parkinson's disease	5.43e-06	3.29e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GPX1—Parkinson's disease	5.36e-06	3.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.22e-06	3.16e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INS—Parkinson's disease	5.17e-06	3.13e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—COMT—Parkinson's disease	5.15e-06	3.11e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.13e-06	3.1e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—Parkinson's disease	5.12e-06	3.1e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MAOA—Parkinson's disease	5.11e-06	3.09e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.07e-06	3.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—Parkinson's disease	5.05e-06	3.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TH—Parkinson's disease	5e-06	3.02e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.98e-06	3.02e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	4.94e-06	2.99e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.93e-06	2.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—Parkinson's disease	4.85e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.8e-06	2.9e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—Parkinson's disease	4.71e-06	2.85e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—COMT—Parkinson's disease	4.62e-06	2.8e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—Parkinson's disease	4.6e-06	2.78e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	4.6e-06	2.78e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MAOA—Parkinson's disease	4.59e-06	2.78e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	4.55e-06	2.75e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	4.54e-06	2.74e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	4.52e-06	2.74e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GPX1—Parkinson's disease	4.51e-06	2.73e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.35e-06	2.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—COMT—Parkinson's disease	4.25e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.23e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.23e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.22e-06	2.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	4.18e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.17e-06	2.52e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—Parkinson's disease	4.16e-06	2.52e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPX1—Parkinson's disease	4.05e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4e-06	2.42e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—INS—Parkinson's disease	3.93e-06	2.38e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.89e-06	2.35e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—Parkinson's disease	3.87e-06	2.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	3.85e-06	2.33e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	3.82e-06	2.31e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.73e-06	2.26e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.72e-06	2.25e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.67e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.6e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.54e-06	2.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—Parkinson's disease	3.48e-06	2.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.43e-06	2.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.35e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.32e-06	2.01e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—INS—Parkinson's disease	3.31e-06	2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TH—Parkinson's disease	3.27e-06	1.98e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—Parkinson's disease	3.2e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.14e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—INS—Parkinson's disease	2.97e-06	1.8e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COMT—Parkinson's disease	2.78e-06	1.68e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.77e-06	1.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.76e-06	1.67e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—INS—Parkinson's disease	2.73e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.73e-06	1.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—Parkinson's disease	2.67e-06	1.62e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.62e-06	1.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.54e-06	1.54e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.43e-06	1.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—Parkinson's disease	2.26e-06	1.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.25e-06	1.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.09e-06	1.27e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—INS—Parkinson's disease	1.79e-06	1.08e-05	CbGpPWpGaD
